EXECUTIVE CHANGES: Former Standard Life, Lloyd s CFO to be Numis chair lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.
A Scottish chemist has joined the board of Rua Life Sciences. Caroline Stretton has been with the Aim-listed medical devices developer as its chief operating officer since Aortech International
Unaudited Interim Results RUA Life Sciences plc (AIM: RUA), the holding company of a group of medical device businesses focused on the exploitation of Elast-Eon™, a long-term implantable biostable polymer , announces its unaudited interim results for the six months ended 30 September 2020. Highlights · Products on schedule for regulatory submission in 2021 · Positive testing on polymeric heart valve · The Group s cash continues to be well managed with cash at 30 September 2020 of £1,009,000 (31 March 2020: £1,976,000) and £1,440,000 at 30 November 2020 Bill Brown, Executive Chairman of RUA Life Sciences, said: A huge amount has been achieved by the team at RUA over the period and the business is now poised to successfully commercialise the vascular grafts and further develop our pioneering work in polymeric heart valves